You are here: Industry Insights > aurobindo pharma

News List

Aurobindo Pharma to make COVAXX’s potential COVID-19 vaccine for India, UNICEF expresspharma
December 25, 2020
Currently, Aurobindo can produce 220 million doses, but is ramping up its facilities to reach a capacity of nearly 480 million by June 2021.
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma expresspharma
December 01, 2020
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including COVID-19.
Aurobindo Pharma to sell US subsidiary to New Mountain Capital affiliate pharmaceutical-technology
October 29, 2020
Indian firm Aurobindo Pharma has entered into a definitive agreement to sell its US subsidiary Natrol to an affiliate of New Mountain Capital in an all-cash transaction valued at Rs40.48bn ($550m).
Aurobindo Pharma to divest Natrol to New Mountain Capit expresspharma
October 28, 2020
Aurobindo Pharma has reached a definitive agreement to sell Natrol, a wholly owned subsidiary of Aurobindo Pharma US, to an affiliate of New Mountain Capital to combine with Jarrow Formulas.
Aurobindo Pharma receives USFDA approval for Acetaminophen Injection expresspharma
October 23, 2020
It is indicated for the treatment of mild to moderate pain in adult and paediatric patients two years and older.
Aurobindo Pharma acquires 100 per cent share of Eugia Pharma Specialities expresspharma
October 19, 2020
Aurobindo Pharma has entered into a share purchase agreement to acquire 100 per cent equity share capital of MViyeS Pharma Ventures.
Merck files petition in US court against Aurobindo Pharma for Janumet expresspharma
August 27, 2020
In June, Merck had filed a petition against Dr Reddy's Laboratories in a US court over similar patent issues on Janumet and Januvia.
Aurobindo Pharma expects Phase I and II trials of COVID-19 vaccine by end of 2020 expresspharma
August 17, 2020
The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by October and the commercial facility by March, next year.
Aurobindo Pharma joins COVID-19 vaccine hunt expresspharma
August 10, 2020
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022.
Aurobindo Pharma plans to launch 50-60 products in US in FY21 expresspharma
June 23, 2020
Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.

Previous page 1 2 3 Next page